PT Kalbe Farma Tbk. (PTKFY)

Market Cap	2.01B -38.1%
Revenue (ttm)	2.11B +13.0%
Net Income	201.77M +5.8%
EPS	0.00 +6.8%
Shares Out	n/a
PE Ratio	9.98
Forward PE	9.20
Dividend	0.13 (1.53%)
Ex-Dividend Date	Jun 5, 2026

Volume	9
Open	9.00
Previous Close	8.70
Day's Range	8.70 - 9.00
52-Week Range	7.63 - 16.36
Beta	-0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,806
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFY

Financial Performance

In 2025, PT Kalbe Farma Tbk.'s revenue was 35.32 trillion, an increase of 8.27% compared to the previous year's 32.63 trillion. Earnings were 3.66 trillion, an increase of 13.09%.

Financial numbers in IDR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 7, 2026

Data Sources Report a data error